Robert D. Sindelar, Ph.D.
Dr. Robert D. Sindelar returned to The University of British Columbia after he was appointed Dean, The Faculty of Pharmaceutical Sciences on September 1, 2002. This followed 19 years at the University of Mississippi where, for the last nine years of his tenure, he held the position of Professor and Chair of Medicinal Chemistry, School of Pharmacy and served as Interim Dean for a 1.5-year period from 2000 to 2001. Prior to his academic appointment at the University of Mississippi, he completed his postdoctoral study at UBC and the State University of New York at Buffalo. Dr. Sindelar obtained a B.A. degree in chemistry from Millikin University (1974) and M.S. (1975) and Ph.D. degrees (1980) from the College of Pharmacy at The University of Iowa. Dr. Sindelar’s expertise lies in medicinal chemistry, computer-aided drug discovery and design, and pharmaceutical biotechnology. He maintained an active research program that focused on the human immune system and drug design for related diseases. This work resulted in more than $14 million in extramural funding as Principle (PI) and Co-PI Investigator, about 45 refereed journal articles, six U.S. patents, several foreign patents and over 70 scientific presentations. He serves as a member of the editorial boards of various scientific journals, including The APhA Biotechnology Initiative, Current Medicinal Chemistry and IDrugs: The Investigational New Drug Journal. In addition to his leadership role in the Faculty, Dr. Sindelar continues to teach in the professional undergraduate curriculum in several courses, and is an active advocate for the profession of pharmacy. About the lecture
|
"